Oncolytic virus

Results: 117



#Item
91Biotechnology Days May 6 and 7, 2014 For students in grades 9 to 12 The perfect opportunity for your students to explore potential careers in biotechnology-related fields

Biotechnology Days May 6 and 7, 2014 For students in grades 9 to 12 The perfect opportunity for your students to explore potential careers in biotechnology-related fields

Add to Reading List

Source URL: sciencetech.technomuses.ca

Language: English - Date: 2014-03-19 13:09:04
92Biotechnology Days May 6 and 7, 2014 For students in grades 9 to 12 The perfect opportunity for your students to explore potential careers in biotechnology-related fields

Biotechnology Days May 6 and 7, 2014 For students in grades 9 to 12 The perfect opportunity for your students to explore potential careers in biotechnology-related fields

Add to Reading List

Source URL: www.sciencetech.technomuses.ca

Language: English - Date: 2014-03-19 13:09:04
93Novel breakthrough in cancer therapy research leads PsiOxus Therapeutics to be named the Most Innovative European Biotech SME in[removed]Brussels,2nd OctoberThe winner of the 2013 EuropaBio Most Innovative European Biotech

Novel breakthrough in cancer therapy research leads PsiOxus Therapeutics to be named the Most Innovative European Biotech SME in[removed]Brussels,2nd OctoberThe winner of the 2013 EuropaBio Most Innovative European Biotech

Add to Reading List

Source URL: www.europabio.org

Language: English - Date: 2013-10-03 03:52:49
941 Chapter 1 Translational Cancer Research: Gene Therapy by Viral and

1 Chapter 1 Translational Cancer Research: Gene Therapy by Viral and

Add to Reading List

Source URL: media.wiley.com

Language: English - Date: 2014-02-17 07:15:08
95Gene Therapy and Molecular Biology Vol 13, page 36 Gene Ther Mol Biol Vol 13, 36-52, 2009 Combination of immunotherapy with anaerobic bacteria for immunogene therapy of solid tumours Review Article

Gene Therapy and Molecular Biology Vol 13, page 36 Gene Ther Mol Biol Vol 13, 36-52, 2009 Combination of immunotherapy with anaerobic bacteria for immunogene therapy of solid tumours Review Article

Add to Reading List

Source URL: www.gtmb.org

Language: English - Date: 2011-11-07 02:17:41
96For personal use only ASX and Media Release 22 October 2012 Sydney

For personal use only ASX and Media Release 22 October 2012 Sydney

Add to Reading List

Source URL: www.viralytics.com

Language: English - Date: 2013-11-13 18:35:56
97For personal use only ASX and Media Release Progress in CAVATAK Phase 2 Melanoma Trial Updated data presented at Immunotherapy Session of American

For personal use only ASX and Media Release Progress in CAVATAK Phase 2 Melanoma Trial Updated data presented at Immunotherapy Session of American

Add to Reading List

Source URL: www.asx.com.au

Language: English - Date: 2014-06-02 20:01:50
98For personal use only ASX and Media Release CAVATAK Cancer Immunotherapy: Progress in Phase 2 Melanoma Trial

For personal use only ASX and Media Release CAVATAK Cancer Immunotherapy: Progress in Phase 2 Melanoma Trial

Add to Reading List

Source URL: www.asx.com.au

Language: English - Date: 2014-05-14 20:06:35
99CALM study: A phase II study of an intratumorally delivered oncolytic immunotherapeutic agent, Coxsackievirus A21, in patients with stage IIIc and stage IV malignant melanoma. Robert H.I. Andtbacka, Brendan Curti, Howard

CALM study: A phase II study of an intratumorally delivered oncolytic immunotherapeutic agent, Coxsackievirus A21, in patients with stage IIIc and stage IV malignant melanoma. Robert H.I. Andtbacka, Brendan Curti, Howard

Add to Reading List

Source URL: www.viralytics.com

Language: English - Date: 2014-06-02 19:54:51
100Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases

Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English